“第四十八章 开发癌症疫苗”版本间的差异
来自cslt Wiki
| 第26行： | 第26行： | ||
==开发者资源== | ==开发者资源== | ||
| − | * Source Code for | + | * Source Code for DeepNovo[https://www.nature.com/articles/s42256-020-00260-4#MOESM2] [https://github.com/nh2tran/DeepNovoAA] |
==高级读者== | ==高级读者== | ||
2022年8月25日 (四) 08:04的版本
教学资料
扩展阅读
视频展示
演示链接
开发者资源
高级读者
- Hu Z, Ott P A, Wu C J. Towards personalized, tumour-specific, therapeutic vaccines for cancer[J]. Nature Reviews Immunology, 2018, 18(3): 168-182. [9]
- Andreatta, M. & Nielsen, M. Gapped sequence alignment using artificial neural networks: application to the MHC class I system. Bioinformatics 32, 511–517 (2016).
- Calling cancer’s bluff with neoantigen vaccines， https://www.nature.com/articles/d41586-017-08706-3
- Ngoc Hieu Tran, Rui Qiao, Lei Xin, Xin Chen, Baozhen Shan，Ming Li， Personalized deep learning of individual immunopeptidomes to identify neoantigens for cancer vaccines， Nature Machine Intelligence, 2, pages764–771(2020) [10]
